NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

The U.S. Food and Drug Administration has given the OK for DCVax-Prostate, which is used to treat late-stage prostate cancer.

If the FDA had approved DCVax-Prostate then NWBO’s share price would not be in the toilet.

DCVax-Prostate had a ‘pending’ Phase 3 trial for years before NWBO quietly stopped saying anything about it. It’s nowhere near approval let alone already approved.

With that big a detail dead wrong, I would not trust any other information in there.